Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.70
+0.13 (0.51%)
At close: Dec 4, 2025, 4:00 PM EST
25.68
-0.02 (-0.08%)
After-hours: Dec 4, 2025, 7:59 PM EST
Pfizer Employees
Pfizer had 81,000 employees as of December 31, 2024. The number of employees decreased by 7,000 or -7.95% compared to the previous year.
Employees
81,000
Change (1Y)
-7,000
Growth (1Y)
-7.95%
Revenue / Employee
$775,123
Profits / Employee
$121,346
Market Cap
146.12B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
| Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
| Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
| Dec 31, 2021 | 79,000 | 500 | 0.64% |
| Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
| Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
| Dec 31, 2018 | 92,400 | 2,200 | 2.44% |
| Dec 31, 2017 | 90,200 | -6,300 | -6.53% |
| Dec 31, 2016 | 96,500 | -1,400 | -1.43% |
| Dec 31, 2015 | 97,900 | 19,600 | 25.03% |
| Dec 31, 2014 | 78,300 | 600 | 0.77% |
| Dec 31, 2013 | 77,700 | -13,800 | -15.08% |
| Dec 31, 2012 | 91,500 | -12,200 | -11.76% |
| Dec 31, 2011 | 103,700 | -6,900 | -6.24% |
| Dec 31, 2010 | 110,600 | -5,900 | -5.06% |
| Dec 31, 2009 | 116,500 | 34,700 | 42.42% |
| Dec 31, 2008 | 81,800 | -4,800 | -5.54% |
| Dec 31, 2007 | 86,600 | -11,400 | -11.63% |
| Dec 31, 2006 | 98,000 | -8,000 | -7.55% |
| Dec 31, 2005 | 106,000 | -9,000 | -7.83% |
| Dec 31, 2004 | 115,000 | -7,000 | -5.74% |
| Dec 31, 2003 | 122,000 | 24,000 | 24.49% |
| Dec 31, 2002 | 98,000 | 8,000 | 8.89% |
| Dec 31, 2001 | 90,000 | 0 | - |
| Dec 31, 2000 | 90,000 | 39,100 | 76.82% |
| Dec 31, 1999 | 50,900 | 4,500 | 9.70% |
| Dec 31, 1998 | 46,400 | -2,800 | -5.69% |
| Dec 31, 1997 | 49,200 | 2,700 | 5.81% |
| Dec 31, 1996 | 46,500 | 2,700 | 6.16% |
| Dec 31, 1995 | 43,800 | 3,000 | 7.35% |
| Dec 31, 1994 | 40,800 | 300 | 0.74% |
| Dec 31, 1993 | 40,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PFE News
- 2 days ago - 17 dividend-stock bargains from a value manager with a stellar track record - Market Watch
- 2 days ago - 2 Top Dividend Stocks to Buy Now and Hold For a Decade - The Motley Fool
- 3 days ago - FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
- 3 days ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 3 days ago - Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance - Business Wire
- 3 days ago - 2 Undervalued, High-Quality Companies to Buy Now and Hold Forever - The Motley Fool
- 4 days ago - This 7% Yielder Could Be a Top AI Play - The Motley Fool
- 4 days ago - 3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio - The Motley Fool